Literature DB >> 11904435

Profound defects in pancreatic beta-cell function in mice with combined heterozygous mutations in Pdx-1, Hnf-1alpha, and Hnf-3beta.

David Q Shih1, Markus Heimesaat, Satoru Kuwajima, Roland Stein, Christopher V E Wright, Markus Stoffel.   

Abstract

Defects in pancreatic beta-cell function contribute to the development of type 2 diabetes, a polygenic disease that is characterized by insulin resistance and compromised insulin secretion. Hepatocyte nuclear factors (HNFs) -1alpha, -3beta, -4alpha, and Pdx-1 contribute in the complex transcriptional circuits within the pancreas that are involved in beta-cell development and function. In mice, a heterozygous mutation in Pdx-1 alone, but not Hnf-1alpha(+/-), Hnf-3beta(+/-), or Hnf-4alpha(+/-), causes impaired glucose-stimulated insulin secretion in mice. To investigate the possible functional relationships between these transcription factors on beta-cell activity in vivo, we generated mice with the following combined heterozygous mutations: Pdx-1(+/-)/Hnf-1alpha(+/-), Pdx-1(+/-)/Hnf-3beta(+/-), Pdx-1(+/-)/Hnf-4alpha(+/-), Hnf-1alpha(+/-)/Hnf-4alpha(+/-), and Hnf-3beta(+/-)/Hnf-4alpha(+/-). The greatest loss in function was in combined heterozygous null alleles of Pdx-1 and Hnf-1alpha (Pdx-1(+/-)/Hnf-1alpha(+/-)), or Pdx-1 and Hnf-3beta (Pdx-1(+/-)/Hnf-3beta(+/-)). Both double mutants develop progressively impaired glucose tolerance and acquire a compromised first- and second-phase insulin secretion profile in response to glucose compared with Pdx-1(+/-) mice alone. The loss in beta-cell function in Pdx-1(+/-)/Hnf-3beta(+/-) mice was associated with decreased expression of Nkx-6.1, glucokinase (Gck), aldolase B (aldo-B), and insulin, whereas Nkx2.2, Nkx-6.1, Glut-2, Gck, aldo-B, the liver isoform of pyruvate kinase, and insulin expression was reduced in Pdx-1(+/-)/Hnf-1alpha(+/-) mice. The islet cell architecture was also abnormal in Pdx-1(+/-)/Hnf-3beta(+/-) and Pdx-1(+/-)/Hnf-1alpha(+/-) mice, with glucagon-expressing cells scattered throughout the islet, a defect that may be connected to decreased E-cadherin expression. Our data suggest that functional interactions between key islet regulatory factors play an important role in maintaining islet architecture and beta-cell function. These studies also established polygenic mouse models for investigating the mechanisms contributing to beta-cell dysfunction in diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11904435      PMCID: PMC122607          DOI: 10.1073/pnas.062605899

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Pancreatic beta cell-specific transcription of the pdx-1 gene. The role of conserved upstream control regions and their hepatic nuclear factor 3beta sites.

Authors:  K Gerrish; M Gannon; D Shih; E Henderson; M Stoffel; C V Wright; R Stein
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

2.  An early developmental transcription factor complex that is more stable on nucleosome core particles than on free DNA.

Authors:  L A Cirillo; K S Zaret
Journal:  Mol Cell       Date:  1999-12       Impact factor: 17.970

Review 3.  Regulation of insulin gene transcription.

Authors:  K Ohneda; H Ee; M German
Journal:  Semin Cell Dev Biol       Date:  2000-08       Impact factor: 7.727

Review 4.  Developmental biology of the pancreas.

Authors:  H Edlund
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

5.  A transcription factor regulatory circuit in differentiated pancreatic cells.

Authors:  S F Boj; M Parrizas; M A Maestro; J Ferrer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

6.  Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2.

Authors:  Y Kido; D J Burks; D Withers; J C Bruning; C R Kahn; M F White; D Accili
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

7.  Functional conservation of regulatory elements in the pdx-1 gene: PDX-1 and hepatocyte nuclear factor 3beta transcription factors mediate beta-cell-specific expression.

Authors:  S Marshak; E Benshushan; M Shoshkes; L Havin; E Cerasi; D Melloul
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

8.  Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism.

Authors:  D Q Shih; S Screenan; K N Munoz; L Philipson; M Pontoglio; M Yaniv; K S Polonsky; M Stoffel
Journal:  Diabetes       Date:  2001-11       Impact factor: 9.461

9.  Tissue-specific deletion of Foxa2 in pancreatic beta cells results in hyperinsulinemic hypoglycemia.

Authors:  N J Sund; M Z Vatamaniuk; M Casey; S L Ang; M A Magnuson; D A Stoffers; F M Matschinsky; K H Kaestner
Journal:  Genes Dev       Date:  2001-07-01       Impact factor: 11.361

10.  Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas.

Authors:  M Sander; L Sussel; J Conners; D Scheel; J Kalamaras; F Dela Cruz; V Schwitzgebel; A Hayes-Jordan; M German
Journal:  Development       Date:  2000-12       Impact factor: 6.868

View more
  32 in total

Review 1.  Transcriptional networks controlling pancreatic development and beta cell function.

Authors:  J M Servitja; J Ferrer
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

2.  Diabetes and pancreatic cancer.

Authors:  Donghui Li
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

3.  Development of novel cell lines of diabetic dysfunction model fit for cell-based screening tests of medicinal materials.

Authors:  Mikako Saito; Aya Hayakawa; Nobuya Inagaki; Hideaki Matsuoka
Journal:  Cytotechnology       Date:  2012-07-10       Impact factor: 2.058

4.  Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance.

Authors:  Yasuo Terauchi; Iseki Takamoto; Naoto Kubota; Junji Matsui; Ryo Suzuki; Kajuro Komeda; Akemi Hara; Yukiyasu Toyoda; Ichitomo Miwa; Shinichi Aizawa; Shuichi Tsutsumi; Yoshiharu Tsubamoto; Shinji Hashimoto; Kazuhiro Eto; Akinobu Nakamura; Mitsuhiko Noda; Kazuyuki Tobe; Hiroyuki Aburatani; Ryozo Nagai; Takashi Kadowaki
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

5.  Targeted deletion of a cis-regulatory region reveals differential gene dosage requirements for Pdx1 in foregut organ differentiation and pancreas formation.

Authors:  Yoshio Fujitani; Shuko Fujitani; Daniel F Boyer; Maureen Gannon; Yoshiya Kawaguchi; Michael Ray; Masakazu Shiota; Roland W Stein; Mark A Magnuson; Christopher V E Wright
Journal:  Genes Dev       Date:  2006-01-15       Impact factor: 11.361

6.  Pancreatic-duodenal homeobox 1 regulates expression of liver receptor homolog 1 during pancreas development.

Authors:  Jean-Sébastien Annicotte; Elisabeth Fayard; Galvin H Swift; Lars Selander; Helena Edlund; Toshiya Tanaka; Tatsuhiko Kodama; Kristina Schoonjans; Johan Auwerx
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

7.  Role of Foxa-2 in adipocyte metabolism and differentiation.

Authors:  Christian Wolfrum; David Q Shih; Satoru Kuwajima; Andrew W Norris; C Ronald Kahn; Markus Stoffel
Journal:  J Clin Invest       Date:  2003-07-15       Impact factor: 14.808

Review 8.  Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity.

Authors:  Joseph Fomusi Ndisang
Journal:  Mediators Inflamm       Date:  2010-05-18       Impact factor: 4.711

9.  Epistasis of transcriptomes reveals synergism between transcriptional activators Hnf1alpha and Hnf4alpha.

Authors:  Sylvia F Boj; Dimitri Petrov; Jorge Ferrer
Journal:  PLoS Genet       Date:  2010-05-27       Impact factor: 5.917

10.  Activation of PyMT in beta cells induces irreversible hyperplasia, but oncogene-dependent acinar cell carcinomas when activated in pancreatic progenitors.

Authors:  Yi-Chieh Nancy Du; David S Klimstra; Harold Varmus
Journal:  PLoS One       Date:  2009-09-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.